🌞 With #ESMO2024 happening in Barcelona, I'm reminded of the great symposium we delivered at ESMO Breast earlier this year. If you missed it, catch it on demand now! 🔬 Optimizing Curative Intent Therapy in HER2-Positive Early Breast Cancer 🎗️ This program, led by experts Volkmar Müller, Lesley Fallowfield, and Qiang Liu, provides key insights into HER2-targeted therapies and real-world evidence to improve patient care. 👉 Watch on demand: https://lnkd.in/eXNf92Vp #MedscapeEducation #OncologyEducation #BreastCancer #PatientOutcomes
Margaux Le Berre’s Post
More Relevant Posts
-
Discover how Brazil's public consultation on Trastuzumab, a key drug for early-stage breast cancer, led to its inclusion in the SUS. Learn about the power of public engagement and evidence-based decision-making in shaping healthcare policies. #HealthcarePodcast #BrazilHealthcare #Trastuzumab #BreastCancerAwareness #PublicConsultation #HealthTechAssessment #CONITEC #PublicHealth #LifeSavingDecisions #HealthcareTransparency
To view or add a comment, sign in
-
What is top of mind for breast cancer industry experts during #BreastCancerAwarenessMonth? Emily Castellanos, MD, MPH, Senior Medical Director at Flatiron Health, recently sat down with experts from across #clinicalresearch, drug commercialization and clinical practice to discuss the current and future state of #breastcancer research and care. To learn more, you can read the full article here: https://lnkd.in/eh_fnaVB
To view or add a comment, sign in
-
-
Welcome Post: "🎗️ Welcome to OncoWellness on LinkedIn! We're a healthcare initiative committed to revolutionizing breast cancer prevention in Canada through early detection and awareness. 🌟 Stay connected for updates on cutting-edge technologies, impactful stories, and collaborative opportunities to make a difference. Let's work together to create a healthier future. 💗 #BreastCancerAwareness #OncoWellness #HealthcareInnovation"
OncoWellness | LinkedIn
linkedin.com
To view or add a comment, sign in
-
#Leadership plays a crucial role in improving breast cancer outcomes and promoting #healthcare equity. This month’s newsletter focuses on how leadership influences early detection, support systems, and research during #BreastCancerAwareness Month. Discover how our Fellows are working to address these challenges and how you can get involved in supporting these efforts. Learn more: https://lnkd.in/gxz55as2
To view or add a comment, sign in
-
-
🎗️ This #BreastCancerAwarenessMonth, we recognize the pivotal role researchers play in advancing breast cancer treatments and diagnostics. Their groundbreaking work leads to more effective therapies, earlier detection, and improved outcomes for patients globally. Let’s honor their dedication and continue supporting the innovation that drives progress. #BreastCancerAwarenessMonth #BreastCancerResearch #MedicalInnovation #Healthcare
To view or add a comment, sign in
-
-
Unlock the future of oncology care with cutting-edge oncology informatics tools and software! These innovative tools empower clinicians to be proactive, relentless, and visionary in their fight against cancer. By streamlining data and enhancing patient care, they make a real difference in the lives of both doctors and patients. In this article Elekta 's own Anish Patankar dives in to how these game-changers can transform clinical practice. #ElektaONE #OIS #OncologyInformatics #MOSAIQ #Monaco #TPS https://elekta.smh.re/7uh
To view or add a comment, sign in
-
-
Dr. Vernon Sondak talks about how critically important the data from clinical trials are in shaping new standards of care and in developing better treatment options for cancer patients. __________________________________________________ 🔬 Don't miss out on the latest developments in oncology! Let us show you how we can get the insights you need, from the HCPs you want to hear from - even during busy congress season! #immunotherapy #neoadjuvanttherapy #ClinicalTrials #ESMO24
To view or add a comment, sign in
-
Cancer is a looming threat that affects all of us, with incidence projected to increase over the next 25 years, according to the American Cancer Society. Awny Farajallah, MD, FACP, Chief Medical Officer, Global Oncology, says we need solutions now. Read more about how we can bring these solutions to patients faster by rethinking #ClinicalTrial design. Learn more in STAT: https://lnkd.in/evpx8r-x
Challenging the Status Quo: Rethinking Standardized Clinical Endpoints
To view or add a comment, sign in
-
Florida Blue is revolutionizing cancer care for thousands of its members with a new comprehensive oncology care model that provides faster access to high-quality treatment and personalized support. By partnering with The Oncology Institute and Sanitas Medical Centers, #Florida Blue is setting a new standard for oncology care, and this article explores the innovative approach and its potential to improve health outcomes and make care more affordable. Check out this article for more information! 💻https://lnkd.in/e-HVpgJe #CancerCareInnovation #ValueBasedCare #FloridaBlueCares
To view or add a comment, sign in
-
-
How do healthcare professionals discuss breast cancer on the world's largest online global physicians' community, G-Med? They talk most about quality of life, and neoadjuvant and adjuvant therapy. Discover more in our latest research through CREATION.co' partnership with G-Med. Read the full analysis: https://lnkd.in/eKCkdXr3 Follow CREATION.co for the latest insights on online HCPs and DOLs.
To view or add a comment, sign in
-